Shares of Spectral Medical Inc. (TSE:EDT - Get Free Report) were down 1.8% during mid-day trading on Thursday . The company traded as low as C$0.54 and last traded at C$0.54. Approximately 4,500 shares traded hands during trading, a decline of 94% from the average daily volume of 80,274 shares. The stock had previously closed at C$0.55.
Spectral Medical Price Performance
The firm has a market cap of C$146.25 million, a PE ratio of -7.43 and a beta of 0.96. The company has a current ratio of 0.61, a quick ratio of 0.45 and a debt-to-equity ratio of 26.03. The company has a 50 day moving average price of C$0.57 and a 200 day moving average price of C$0.56.
Spectral Medical (TSE:EDT - Get Free Report) last posted its earnings results on Friday, November 8th. The company reported C($0.04) EPS for the quarter. The business had revenue of C$0.50 million during the quarter. On average, sell-side analysts expect that Spectral Medical Inc. will post -0.05 EPS for the current year.
Insider Activity
In related news, Director Paul M. Walker sold 150,000 shares of the company's stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of C$0.65, for a total transaction of C$97,500.00. Company insiders own 18.18% of the company's stock.
Spectral Medical Company Profile
(
Get Free Report)
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Further Reading
Before you consider Spectral Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.
While Spectral Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
